Table 1 Analysis of the differences in characteristics between IDUr and n-IDUr.
From: Explainable illicit drug abuse prediction using hematological differences
Variables | Non-IDU (n=248) | IDU (n=244) | P value |
|---|---|---|---|
Cl, mmol/L | 103.5 [100.6–105.3] | 16.0 [14.9–17.4] | < 0.001 |
RBP, ug/ml | 33.8 [26.4–40.6] | 25.0 [17.2–32.1] | < 0.001 |
eGFR, mL/min | 92.6 [76.1–106.5] | 73.72 [38.7–89.6] | < 0.001 |
Folate, nmol/L | 5.8 [4.1–8.6] | 3.3 [2.2–4.4] | < 0.001 |
CHOL, mmol/L | 4.7 [4.1–5.4] | 3.9 [3.4–4.7] | < 0.001 |
BHB, mmol/L | 0.06 [0.03–0.16] | 0.3 [0.18–0.5] | < 0.001 |
PCT, \(\%\) | 0.25 [0.21–0.29] | 0.2 [0.16–0.24] | < 0.001 |
HFLC=0, \(\%\) | 53(21.4) | 244(100) | < 0.001 |
T3, ng/ml | 1.02 [0.88–1.16] | 1.20 [0.99–1.36] | < 0.001 |
NRBC=0, \(\%\) | 60(24.2) | 12(4.9) | < 0.001 |
CHE, U/L | 9.1 [7.7–10.4] | 8.1 [6.4–9.5] | < 0.001 |
ApoB, g/L | 0.92 [0.74–1.11] | 0.75 [0.62–0.93] | < 0.001 |
HCO3, mmol/L | 19.1 [17.6–20.4] | 17.9 [16.3–19.1] | < 0.001 |
PLT, \(10^{9}\)/L | 238 [195–282] | 197 [146–243] | < 0.001 |
CYSC, mg/L | 0.89 [0.75–1.04] | 0.98 [0.85–1.48] | < 0.001 |
UA, mmol/L | 362.7 [301.8–450.5] | 335.4 [233.8–398.2] | < 0.001 |
Zn, umol/L | 11.2 [9.2–12.7] | 9.8 [7.2–12.4] | < 0.001 |
ALB, g/L | 48.7 [46.3–51.2] | 47.0 [44.9–48.9] | < 0.001 |
LDL-C, mmol/L | 2.77 [2.33–3.40] | 2.39 [1.81–2.97] | < 0.001 |
TP, g/L | 76.3 [73.2–78.9] | 74.9 [71.9–78.7] | < 0.001 |
ApoA−1, g/L | 1.40 [1.23–1.53] | 1.27 [1.16–1.42] | < 0.001 |
HCY, umol/L | 16.7 [14.0–20.1] | 18.5 [15.2–26.4] | < 0.001 |
IgA, g/L | 2.56 [1.91–3.19] | 2.26 [1.65–2.80] | < 0.001 |
FRUC, umol/L | 264.5 [245.6–279.0] | 250.7 [232.4–266.9] | < 0.001 |
HbA1c, \(\%\) | 5.9 [5.6–6.2] | 5.8 [5.6–6.1] | < 0.001 |
PDW, \(\%\) | 12.2 [11.2–13.6] | 11.5 [10.4–12.8] | < 0.001 |
P-LCR, \(\%\) | 29.7 [24.4–34.6] | 26.7 [22.1–32.5] | < 0.001 |
VitB12, pmol/L | 372 [274–521] | 248 [169–348] | < 0.001 |